Psilocybin Shows Promise for Cocaine Addiction
A clinical trial found a single dose of psilocybin may effectively treat cocaine addiction, showing higher abstinence rates than a placebo.
Lauren Collins ·
Psilocybin Shows Promise for Cocaine Addiction
A recent clinical trial published in Jama Network Open indicates that a single dose of psilocybin may be an effective treatment for cocaine addiction. The study, conducted by researchers including Dr. Peter Hendricks of the University of Alabama at Birmingham, found that 19 participants who received psilocybin demonstrated a higher likelihood of abstaining from cocaine compared to 17 participants who received a placebo.
The mechanism of action for psilocybin in this context is believed to involve increased neuroplasticity and psychological plasticity, facilitating changes in thinking and behavior. Unlike many addiction medications that target neurochemical systems similar to the addictive substance, psilocybin induces a profound altered state of consciousness within a structured psychotherapy context. This single-session intervention acts as a catalyst for shifts in perspective and self-compassion, which can aid behavioral modification, particularly for cocaine addiction where withdrawal symptoms are primarily psychological.
The study is notable for its inclusion of a majority of Black participants, addressing a demographic imbalance often observed in psychedelic clinical trials. While the study excluded individuals with comorbid depression and anxiety, experts suggest psilocybin's potential to address these conditions, which also involve rigid thought patterns, could broaden its applicability. Further large-scale clinical trials are recommended to validate these findings and explore broader applications.